David S. Bredt
David S. Bredt is an American molecular neuroscientist who has been Global Head Discovery Neuroscience at Johnson & Johnson since 2011.[1]
After studies in chemistry at Princeton, Bredt studied medicine at Johns Hopkins School of Medicine where he obtained M.D and Ph.D degrees. He was a student of Solomon H. Snyder whom he also co-authored several widely cidely papers.[2] He worked as a postdoctoral fellow in the Department of Neuroscience at Johns Hopkins from 1993 to 1994.[3] He became a 1995 Searle scholar,[4] and received a 1997 Beckman Young Investigators Award.
He worked at the University of California, San Francisco Medical school from 1994 to 2004, first as an assistant professor,[2] later as professor of physiology.[3]
He served as Vice President of Integrative Biology at Eli Lilly and Company from 2004 to 2011.[5] He was elected to the Johns Hopkins University Society of Scholars in 2005.[3][6]
Selected papers
- Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme PNAS, January 1, 1991, vol 87.
- Localization of nitric oxide synthase indicating a neural role for nitric oxide Nature 347, 768 - 770 (25 October 1990).
- Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum PNAS, 1 November 1989, vol 86.
References
- ^ Jonathan D. Rockoff (3 March 2011 J&J Poaches Lilly’s Neurological Research Chief Wall Street Journal. Retrieved 16 December 2013
- ^ a b Karen Kreeger (2 May 1992) Hot Scientists Have Philosophies In Common The Scientist
- ^ a b c Society of Scholars Inducts New Members The JHU Gazette. 23 May 2005. Retrieved 16 December 2013
- ^ Scholar Profile David S. Bredt
- ^ Jonathan D. Rockoff (24 February 2011) Lilly’s Neuroscience Research Chief Resigns Wall Street Journal. Retrieved 16 December 2013
- ^ Julie Blanker (September 2005) Alumni NotesAlumni Notes Johns Hopkins Magazine. Retrieved 16 December 2013
   | This article about an American scientist is a stub. You can help Wikipedia by expanding it. |